S. Jung

发表

Inhibition of Osteoarthritis-Related Molecules by Isomucronulatol 7-O-β-d-glucoside and Ecliptasaponin A in IL-1β-Stimulated Chondrosarcoma Cell Model

Y. H. Kim, Sung-Hoon Jung, G. Hong, 2018, Molecules.

Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, The Korean journal of internal medicine.

Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation

Sung-Hoon Jung, Choong-Eun Lee, Sumi Kim, 2016, Oncotarget.

Patterns of relapse or progression after bortezomib-based salvage therapy in patients with relapsed/refractory multiple myeloma.

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Clinical lymphoma, myeloma & leukemia.

M. Rhyu, J. Oh, Seung-Jin Hong, 2013, Epigenomics.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Jong-Ho Won, Sang Kyun Sohn, Sung-Hoon Jung, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

M. Minden, S. Ogawa, Namshin Kim, 2015, Haematologica.

Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2018, Front. Immunol..

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

J. Rhee, Je-Jung Lee, Hyun-ju Lee, 2018, Front. Immunol..

Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Oncotarget.

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model

Sung-Hoon Jung, Manh-Cuong Vo, Je-Jung Lee, 2017, Oncotarget.

Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells

Je-Jung Lee, Hyun-Ju Lee, Hyeoung-Joon Kim, 2016, Experimental & Molecular Medicine.

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Chonnam medical journal.

Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2014, Experimental hematology.

Cellular Immunotherapy Using Dendritic Cells in Multiple Myeloma: New Concept to Enhance Efficacy

H. Lee, Je Jung Lee, Youn-Kyung Lee, 2013 .

Slow Overmethylation of Housekeeping Genes in the Body Mucosa Is Associated with the Risk for Gastric Cancer

M. Rhyu, J. Oh, Sung-Hoon Jung, 2014, Cancer Prevention Research.

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Sung-Hoon Jung, 2019, Cancer Immunology, Immunotherapy.

Cellular immunotherapy in multiple myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2019, The Korean journal of internal medicine.

Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event

J. Hwang, I. Chung, W. Bae, 2014, Journal of chemotherapy.

Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, Leukemia research.

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

H. Choi, E. Hwang, J. Hwang, 2011, BMC Cancer.

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2021, Cellular & Molecular Immunology.

Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Sang‐Yun Song, 2021, Journal of Korean medical science.

Diagnostic accuracy and prognostic relevance of immunoglobulin heavy chain rearrangement and 18 F-FDG- PET/CT compared with unilateral bone marrow trephination for detecting bone marrow involvement in patients with diffuse large B-cell lymphoma

Hyeoung-Joon Kim, Je Jung Lee, Deok-Hwan Yang, 2021 .

Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party

Je-Jung Lee, S. Sohn, D. Jo, 2014, Acta Haematologica.

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)

Kihyun Kim, Jin Seok Kim, H. Eom, 2022, Frontiers in Oncology.

Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen

Sukjoong Oh, Jin Seok Kim, Je-Jung Lee, 2015, Annals of Hematology.

STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, M. Shin, 2017, Blood research.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

Zhaolei Zhang, C. Jung, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2012, Case Reports in Oncology.

Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2011, The Korean journal of hematology.

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Kihyun Kim, S. Kim, S. Yoon, 2020, BMC Cancer.

Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma

Je-Jung Lee, Miyoung Kim, Hyeoung-Joon Kim, 2013, Blood research.

Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia

J. Lee, Yunsuk Choi, Y. Do, 2020, Yonsei medical journal.

Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment

Je-Jung Lee, Hyeoung-Joon Kim, Sang‐Yun Song, 2016, Scientific Reports.

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer

E. Hwang, J. Hwang, I. Chung, 2013, BMC Cancer.

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract

Hyun-Sun Lee, B. Yun, Kwang-Won Lee, 2008, Phytotherapy research : PTR.

Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party

Ji‐Hyun Lee, Yunsuk Choi, H. Yhim, 2018, Annals of Hematology.

Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma

I. Oh, Je-Jung Lee, Miyoung Kim, 2013, Tuberculosis and respiratory diseases.

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial

H. Yhim, Je-Jung Lee, Hyeoung-Joon Kim, 2013, Annals of Hematology.

Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Sae-Ryung Kang, H. Yhim, Je-Jung Lee, 2019, Annals of Hematology.

Serum Lactate Dehydrogenase with a Systemic Inflammation Score Is Useful for Predicting Response and Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Acta Haematologica.

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

J. Leonard, B. Cheson, B. Pitcher, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma

J. Min, Y. Do, S. Kweon, 2015, BMC Cancer.

A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2012, Annals of Hematology.

Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)

J. H. Lee, Kihyun Kim, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma

J. H. Lee, Kihyun Kim, Je-Jung Lee, 2022, Annals of Hematology.

Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.

Je-Jung Lee, M. Yoon, Sung-Hoon Jung, 2022, Cytotherapy.

Update on primary plasma cell leukemia

Je-Jung Lee, Sung-Hoon Jung, S. Jung, 2022, Blood research.

Venetoclax with Azacitidine Induced Tumor Lysis Syndrome in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

Sung-Hoon Jung, Jae-Sook Ahn, H. Bang, 2021, Electrolytes & Blood Pressure : E & BP.

The Impact of Hyperglycemia on Risk of Severe Infections during Early Period of Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, BioMed research international.

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells

I. Park, Je-Jung Lee, Hyeoung-Joon Kim, 2015, Journal of immunology research.

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

Junsang Doh, Je-Jung Lee, Hyeoung-Joon Kim, 2021, Cancer Immunology, Immunotherapy.

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2022, Cancer research and treatment.

Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, International Journal of Hematology.

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen

Je-Jung Lee, Miyoung Kim, Hyeoung-Joon Kim, 2012, International Journal of Hematology.

Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy

H. Yhim, Je-Jung Lee, Hyeoung-Joon Kim, 2013, American journal of hematology.

Disease progression patterns of bevacizumab responders with recurrent malignant gliomas

Shin Jung, Kyung-Sub Moon, E. Hwang, 2017, Oncology letters.

Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes

B. Yun, Kwang-Won Lee, Sung-Hoon Jung, 2007, Archives of Toxicology.

Prevalence and Risk Factors for Adrenal Insufficiency in Patients with Multiple Myeloma Receiving Long-Term Chemotherapy including Corticosteroids: A Retrospective Cohort Study

Ho-Cheol Kang, Wonsuk Choi, H. Kim, 2021, BioMed Research International.

Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma

C. Hong, S. Jeong, J. Min, 2020, In Vivo.

Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2015, Chonnam medical journal.

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma

S. Kim, Y. Lee, J. Jo, 2019, Bone Marrow Transplantation.

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2020, Leukemia & lymphoma.

Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Journal of clinical apheresis.

Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

H. Kang, C. Suh, Y. Do, 2015, European journal of haematology.

Frontline therapy for newly diagnosed patients with multiple myeloma

J. Jo, Je-Jung Lee, Hyeoung-Joon Kim, 2019, Blood research.

Adrenal insufficiency in hospitalized patients with multiple myeloma

Ho-Cheol Kang, H. Kim, Je-Jung Lee, 2020, Leukemia & lymphoma.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Experimental hematology.

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study

Yunsuk Choi, H. Yhim, S. Sohn, 2021, The Korean journal of internal medicine.

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Cancer Immunology, Immunotherapy.

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Journal of immunotherapy.

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2018, BMC Cancer.

Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era

J. Min, H. Kim, S. Kweon, 2013, Annals of Hematology.

Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population

J. Jo, Je-Jung Lee, Sangjin Lee, 2021, Scientific Reports.

Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Annals of Hematology.

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

J. Cheong, Kihyun Kim, Jin Seok Kim, 2016, BMC Cancer.

Removal Effect of Hydrogen Water Drinking on Exercise-induced Production of Reactive Oxygen Species in Adult Men and Women

M. Chung, J. Ro, Jae-Yeo Park, 2018, Exercise Science.

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

Je-Jung Lee, Miyoung Kim, Hyeoung-Joon Kim, 2012, Case Reports in Oncology.

Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? a multicenter propensity score-matched analysis.

Myung Soo Kim, Kwangsung Park, E. Hwang, 2017, Oncotarget.

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

Y. K. Park, E. Hwang, J. Hwang, 2013, Clinical & Experimental Metastasis.

BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors

Sung-Soo Yoon, Y. Lee, H. Yhim, 2017, Haematologica.

Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, EJHaem.

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

F. Emmrich, J. Rhee, Je-Jung Lee, 2017, Oncotarget.

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party

J. H. Lee, Kihyun Kim, S. Yoon, 2022, Blood Cancer Journal.

Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial‐unfit patients and subsequent therapy

Kihyun Kim, Sung-Soo Yoon, Je-Jung Lee, 2020, British journal of haematology.

A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System

Kihyun Kim, S. Kim, Jin Seok Kim, 2018, British journal of haematology.

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

Y. K. Park, E. Hwang, J. Hwang, 2013, Clinical & Experimental Metastasis.

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT

C. Hong, S. Jeong, Kihyun Kim, 2021, Blood Cancer Journal.

Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline.

C. Hong, S. Jeong, J. Min, 2021, Clinical lymphoma, myeloma & leukemia.

Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment

C. Hong, S. Jeong, J. Min, 2021, International Journal of Hematology.

18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System

J. Min, Je-Jung Lee, H. Bom, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma

J. Min, Y. Do, S. Kweon, 2015, BMC Cancer.

Immunotherapy for the treatment of multiple myeloma.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Critical reviews in oncology/hematology.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2018, Clinical nuclear medicine.

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2017, Oncotarget.

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016, Journal of Korean medical science.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2016, Annals of Hematology.

Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer

E. Hwang, D. Kwon, J. Hwang, 2016, SpringerPlus.

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2023, The Korean journal of internal medicine.

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen

J. Jo, H. Yhim, Je-Jung Lee, 2022, Blood research.